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Executive Summary
Electronic-cigarettes (e-cigarettes) are battery-powered devices of many different configurations
that deliver vaporized nicotine and other chemicals or flavorings to users, but that do not contain
tobacco or require combustion. E-cigarettes have an internal, rechargeable, battery-operated
heat source that converts liquid nicotine and/or flavorings into a mist or vapor that the user
inhales. These devices are frequently promoted as a healthier or safer alternative to traditional
cigarettes for users and bystanders. Consequently, there has been growing interest among
manufacturers and others to allow e-cigarettes to be used indoors and in other settings where
traditional cigarettes have previously been banned. There has, however, been conflicting and at
times confusing information presented to the public regarding the public health risks and
benefits associated with e-cigarettes. This white paper attempts to present the best available
science on the subject today.
The use of e-cigarettes (or “vaping”) has seen an unprecedented increase worldwide. Vaping
has been promoted as a beneficial smoking cessation tool and/or an alternative nicotine delivery
device that contains no combustion byproducts. However, nicotine is highly addictive.
Furthermore, available research indicates that vaping solutions and their emissions may contain
much more than just nicotine, including aerosolized flavorings, propylene glycol, and other
intentional and unintentional contaminants. These ingredients could present an as-yet undefined
health hazard to both users and bystanders.
Whereas e-cigarette use and exposure may lower some or most risks associated with
conventional cigarette use, the health effects of nicotine and aerosol exposures from ecigarettes are not well-understood at this time. Current research indicates that vaping aerosols
are not without risk, especially for nearby persons in areas with limited ventilation and persons
with compromised health conditions. Limited published studies that evaluated the potential
hazardous effects of the natural and/or synthetic chemicals used in e-cigarettes indicate that
there are potential health effects reported for both users and those exposed secondhand.
Multiple scientific reports express the need for more research. There are several key data gaps
and areas of uncertainty that hinder a more quantitative assessment of health risks related to ecigarettes at this time. These include:
•
•
•
•
•
•
•

Quality control of these products is lacking for both product constituents and labeling.
Laboratory studies may not reflect actual exposures during use because of the variability
in types of devices, user vaping habits and duration, and because many users mix their
own vaping solutions.
There is limited data on chemical emissions/thermal degradation products/exposures
(especially among bystanders and in confined indoor settings).
There is little information on the dynamics of pre and post respiration aerosols and their
fate in the environment.
There is limited information on dose-response relationships for many constituents, such
as short- or long-term health effects associated with low-level exposures, including those
for vulnerable populations.
There is little or no information about the health effects of flavorings that are inhaled
rather than ingested.
There is little information about the synergistic effects from e-cigarette contents and
other environmental contaminants.
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Note that these issues are related only to an assessment of human health risks. They do not
incorporate other potentially important factors, such as public risk perceptions, risk management
options/control measures (e.g., ventilation), and nicotine dependence. In addition, serious safety
issues have been reported and need to be addressed, including child safety and poisonings,
battery explosions, and the potential for the vapor to set off smoke alarms.
Given this review of available information, the existing research does not appear to warrant the
conclusion that e-cigarettes are “safe” in absolute terms. Although they may provide a “safer”
alternative to tobacco cigarettes for the user, these products emit airborne contaminants that
may be inhaled by both the user and those in the vicinity of vaping. Many of the data sources
reviewed confirm that e-cigarettes are not emission-free and that their pollutants could be of
health concern for users and those who are exposed secondhand. Clearly, e-cigarettes lack the
combustion products produced by smoking tobacco, many of which are associated with cancer
development. Although nicotine may not cause cancer, it is associated with other adverse
physiological effects. In addition, the other components in e-cigarettes may not be without risk,
particularly when they are inhaled rather than ingested. Therefore, e-cigarettes should be
considered a source of volatile organic compounds (VOCs) and particulates in the indoor
environment that have not been thoroughly characterized or evaluated for safety.
The Food & Drug Administration (FDA) currently regulates only e-cigarettes that are marketed
for therapeutic purposes. However, the FDA has proposed a rule extending its tobacco product
authorities to include other products like e-cigarettes and the World Health Organization (WHO)
has recommended that consumers be strongly advised not to use electronic nicotine delivery
systems, including e-cigarettes, until they are deemed safe and effective and of acceptable
quality by a competent national regulatory body. Although several agencies and organizations
have adopted restrictions on the use of e-cigarettes in public places, there is currently no U.S.
federal law or regulation that explicitly bans the use of e-cigarettes on airplanes, railroads,
buses, or other modes of transportation.
Because of concerns about primary and secondary exposure to e-cigarette vapors and liquids
(also called “e-juices”), AIHA supports risk-based regulation of e-cigarettes using reliable safety,
health, and emissions data. Four areas of risk based regulation relating to the safety of primary
users and people exposed to secondhand vapors or e-juices should be considered:
1. Physical/Electrical Hazards - All e-cigarette devices, whether they are being used for
therapeutic or recreational purposes, should be evaluated for potential physical and/or
electrical hazards by applicable regulatory agencies.
2. Accidental Exposure - The health risks and economic consequences of accidental
exposure to e-juice liquids by children, adults, and pets should be addressed, including
proper labeling and child-resistant packaging requirements.
3. New Product/New Chemical Use - All future e-juice components that may be used by
consumers should be fully evaluated for any potential hazards (e.g., toxicity,
flammability, safety hazards, and secondary exposures) prior to introduction into the
marketplace.
4. Relationship to Current Smoking Bans - Because e-cigarettes are a potential source of
pollutants (such as airborne nicotine, flavorings, and thermal degradation products), their
use in the indoor environment should be restricted, consistent with current smoking
bans, until and unless research documents that they will not significantly increase the
risk of adverse health effects to room occupants.
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Introduction
E-cigarettes are battery-powered devices of many different configurations that deliver vaporized
nicotine and other chemicals or flavorings to users but that do not contain tobacco or require
combustion. E-cigarettes are the most common type of electronic nicotine delivery systems
(ENDS). Originally patented in 1963 as a smokeless, nontobacco cigarette,[1] these devices
may also be referred to as e-cig, electronic vaping device, personal vaporizer (PV), electronic
hookah, and e-hookah. Because no smoke is generated, e-cigarettes are frequently promoted
as a healthier or safer alternative to traditional cigarettes for users and bystanders.[2]
Consequently, there has been growing interest among manufacturers and others to allow ecigarettes to be used indoors and in other settings where traditional cigarettes have previously
been banned.
There has, however, been conflicting and at times confusing information presented to the public
regarding the public health risks and benefits associated with e-cigarettes. For example, the
Consumer Advocates for Smoke-free Alternatives Association (CASAA), the leading consumer
advocacy group promoting the availability and use of low-risk alternatives to smoking, has
reported that e-cigarettes pose no health concerns and yield a significant risk reduction
compared to regular cigarettes.[2,3] On the other hand, several studies suggest that ecigarettes may cause a variety of short- or long-term health effects, such as increased airway
resistance in the lungs.[4,5,6] The Food and Drug Administration (FDA), a federal agency
responsible for protecting and promoting public health in the United States, has concluded that
the safety and efficacy of e-cigarettes are largely unknown and have not been fully studied.[7]
Similarly, the World Health Organization (WHO) has concluded that the safety and efficacy of
these products has not been scientifically demonstrated and their potential health risks remain
undetermined.[8] The American Lung Association has also issued a statement expressing its
concern about the potential safety and health consequences of e-cigarettes.[9]
Poison control centers have recently warned of an increased rate of poisonings, especially in
children, from the nicotine-containing multi-flavored e-liquids (also called “e-juices”) that are
used to charge e-cigarettes.[10] The use of commercially available flavors of e-liquids that
imitate common food, candy, and liquor flavorings parallels a trend reported in 2007 of the
marketing and use of flavored tobacco products as a gateway for children and young adults to
become regular cigarette smokers.[11] Due to the lack of regulations on vaping, there is
currently no standard message or warning statement on e-cigarette supplies that indicates their
potential danger to the public, especially children. Flavorings and other e-juice additives that
may be acceptable for ingestion are now being inhaled without a clear toxicological
understanding of the potential health effects from a different route of entry.
Although the literature reviewed for this report in most cases supports findings that e-cigarettes
are likely to be much less harmful than tobacco smoking, many questions remain regarding the
potential human health risks posed by the use of e-cigarettes indoors, especially among
bystanders from secondhand and thirdhand exposures. The purpose of this white paper is to
provide a critical and objective review of the available literature on what is currently known and
not known with respect to public exposures and health risks from e-cigarettes. A key outcome of
this review is the identification of key data gaps and areas of uncertainty that hinder a more
quantitative assessment of health risk. Recommendations for additional research are also
provided.
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The aim of this white paper is to present a review of the available scientific evidence-based
literature concerning potential exposures and risks from the use of e-cigarettes, particularly for
persons (especially bystanders) in the indoor environment. As part of this effort, AIHA has
undertaken a search of current and recent past literature using various publication sources (e.g.,
PubMed). Additionally, to capture the rapidly changing landscape of information on e-cigarettes,
we have incorporated Internet sources in an attempt to find original research and newly
published information regarding the health aspects and regulation of e-cigarettes and the
chemical components used therein. Because of the rapidly changing nature of events and
science with respect to e-cigarettes, this white paper presents what is known versus not known
at the time of publication.

How E-cigarettes Work
Early e-cigarettes (first generation) were designed to look like conventional cigarettes. However,
e-cigarettes do not contain tobacco or require a flame to extract the nicotine from the cigarette.
Instead, e-cigarettes have an internal, rechargeable, battery-operated heat source that converts
liquid nicotine and flavorings into a mist or vapor that the user inhales. The inhalation of vapors
from e-cigarettes is commonly called “vaping” instead of “smoking.”

Figure 1: Disposable electronic cigarette resembling a traditional cigarette.

While some e-cigarettes are designed to be totally disposable (see Figure 1), most other ecigarettes contain a rechargeable lithium battery, vaporization chamber, wicking system, and
nicotine/flavoring cartridge. The cartridge containing nicotine liquid is first attached to the
vaporization chamber, which contains an atomizer and/or heating coil. When the user inhales
(from the mouthpiece at the tip of the cartridge), the atomizer is activated and the heating coil
begins to vaporize the liquid. The liquid, in turn, wicks more liquid from the cartridge to the
atomizer. The vaporized liquid cools and condenses into a fine aerosol (called vapor), which is
inhaled, delivering nicotine, diluents, and flavoring(s) to the respiratory tract.
Some first-generation e-cigarettes have a light-up tip that glows when the user inhales to either
simulate a flame and/or to indicate that there is still charge on the attached battery. Second- and
third-generation devices have moved away from looking like tobacco cigarettes (see Figures 2
and 3). These devices have larger batteries and larger e-fluid reservoirs than first-generation ecigarettes and often have variable voltage (vv) or variable wattage (vw) batteries that allow the
user to increase or decrease power to the atomizer. Some devices have a variable airflow
option as well: adjusting the battery voltage or the inhalation air flow can greatly affect the
amount of vapor generated with each puff. After inhalation, the user exhales a portion of the
vapor.
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Figure 2: Second-generation e-cigarettes.

Figure 3: Examples of other kinds of e-cigarettes. By Izord (Own work) [CC-BY-SA-3.0
(http://creativecommons.org/licenses/by-sa/3.0)], via Wikimedia.

Constituents of E-cigarettes: Emissions, Exposures, and Health Risks
Manufactured prepackaged cartridges can be purchased with varying concentrations of nicotine
ranging between 0 and 24 milligrams (mg) of nicotine per cartridge.[12] Nicotine levels,
however, have been found to be inconsistent due to poor quality control.[12] Flavorings are also
frequently added to the liquid, with a variety of flavors available (e.g., tobacco, menthol, mint,
chocolate, coffee, apple, cherry, and caramel). Occasionally, e-cigarettes have been advertised
as containing other drugs, such as tadalifil (a drug used for erectile dysfunction) and rimonabant
(a weight-loss aid).[13] Propylene glycol (PG) and vegetable glycerin are the main components
used in e-liquids as the delivery vehicle and diluent for the nicotine and flavorings, and to
synthesize the tactile sense of smoke (i.e., “vapor”) when the user exhales.[13,14,15]
Many of the toxic and carcinogenic agents in tobacco cigarette smoke are combustion
byproducts, including nitrosamines, VOCs, polycyclic aromatic hydrocarbons (PAHs), and
carbon monoxide. Because e-cigarettes do not have a combustion source, the health risks of
vaping are believed to be greatly reduced compared with traditional cigarette smoking.
However, many potentially toxic compounds are still present in the liquid or vapor components
of e-cigarettes.[14,16] The primary components of electronic cigarette cartridges are propylene
5
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glycol, glycerin, and nicotine.[16] E-cigarettes also contain flavoring agents and other
compounds, and the use of e-cigarettes has been shown to emit aerosols and VOCs, including
nicotine, diethylene glycol, nitrosamines, 1,2-propanediol, acetic acid, acetone, isoprene,
formaldehyde, acetaldehyde, propaldehyde, and flavoring compounds into indoor
air.[7,15,17,18] Additionally, aerosols generated from e-cigarette consumption may contain
various metals and silica particles from wick and heating coil constituents.[19] The following
sections summarize what is currently known and unknown about public exposures and health
risks from the constituents in e-cigarettes.

Nicotine
Nicotine is present in most e-cigarettes and e-liquids. However, advertising and labels for these
products can often be inaccurate regarding their nicotine content.[3] In fact, the FDA reported
that the analysis of many electronic cigarette cartridges that were labeled as containing no
nicotine did, in fact, contain detectable levels of nicotine.[20] Three different cigarette cartridges
that displayed the same label produced varying amounts of nicotine with each puff.[21] A
French study evaluated the nicotine content and labeling of e-cigarettes and found incomplete
or unusable information as well as unreliable labeling.[22] The amounts of nicotine measured in
20 prepackaged cartridge samples were generally higher than was stated on the package and,
in some cases, the nicotine content was found to be two to five times greater.[22]
A review of a number of products purchased online revealed a lack of consistent labeling format
and unclear information regarding nicotine content.[23] In one study, nicotine amounts in 9 out
of 20 analyzed cartridges differed by more than 20 percent from the values declared by their
manufacturers.[24] Several studies found that cartridges labeled as containing nicotine did not
contain any nicotine, while other cartridges labeled as non-nicotine-containing did, in fact,
contain nicotine.[10,15,24] Two studies discovered that, in many cases, nicotine degradation
products and other impurities can be found in refill liquids, such as nicotine-cis-N-oxide,
nicotine-trans-N-oxide, myosmine, anabasine, and anatabine, speculated to be from oxidative
degradation of nicotine occurring either during the manufacturing of the ingredient or during the
manufacturing of the final liquids, or from an unstable formulation[10,25], although the impurities
were reported to be “below the level where they would be likely to cause harm.”[25] Goniewicz
et al. found that in addition to the lack of quality control in content and concentration, some
products are inconsistent in delivering nicotine.[24] In other words, some products may deliver
different levels of nicotine to their users each time they are used even if they use cartridges that
contain the same nicotine content.[24] In addition, because of this inconsistency in nicotine
delivery, or because of the perception that e-cigarettes are “safer” than traditional cigarettes,
users may consume e-cigarettes at a greater rate than traditional cigarettes and, therefore,
generate greater amounts of secondhand contaminants. Therefore, user behavior and overall
quality control of the e-liquids and of the e-cigarette devices may be in question when
attempting to evaluate dosing and user responses.
The health effects of exposure to nicotine are well-documented. The effects of short-term (less
than eight hour) exposures to nicotine at low concentrations are reported to include tremors and
an increase in heart rate, respiratory rate, blood pressure, and level of alertness. Ocular
exposure can cause irritation and redness of the eyes.[26] Ingestion or inhalation of nicotine can
cause nausea, vomiting, abdominal pain, headache, dizziness, confusion, agitation,
restlessness, and possible burning sensation in the mouth, throat, and stomach.[26] Nicotine is
a teratogen,[26] can promote tumor growth[27,28], and has caused abnormalities in the
6
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offspring of laboratory animals.[29] In addition, the National Institute on Drug Abuse states that
nicotine is highly addictive.[30] Addiction to nicotine can occur within days of inhaling one’s first
conventional cigarette.[31] Nicotine increases heart rate, myocardial contractility, and blood
pressure.[32]
Nicotine exposure during pregnancy can potentially cause effects to the unborn child. According
to the Centers for Disease Control and Prevention, nicotine is a teratogen.[26] Prenatal
exposure to nicotine in animal studies with doses as low as 0.5 mg/kg/day have shown learning
and attention deficits in performance in both young and adult rats.[33] Nicotine has also been
demonstrated to produce fetal brain cell damage.[33] An Environmental Protection Agency
study shows that maternal nicotine exposure during fetal development, in doses similar to the
dose of nicotine acquired with moderate smoking (0.5 to 1 pack/day), can result in central
nervous system and neurologic deficits such as impairments in learning and memory
performance.[34] Nicotine acts on specific neurotransmitter receptors in the brain and is a
neuroteratogen, which suggests that some of the adverse perinatal outcomes resulting from
cigarette smoking may in fact be due to nicotine.[35] According to research by Slotkin, the
effects of nicotine on brain development are very similar to those of cocaine.[35]
Study results have confirmed that some e-juices contain amounts of nicotine that are potentially
lethal to both children and adults.[36] Because nicotine can readily pass into the bloodstream
following dermal contact, one study reports that spilling of five milliliters (ml) of e-cigarette liquid
(equivalent to 110 mg of nicotine) onto the skin can cause severe intoxications or even
death.[36] In addition, the tested e-cigarette solutions were found to contain several sensitizing
chemicals, including benzylalcohol and l-limonene, which can cause allergic contact dermatitis
and immediate contact reactions.[36]
Because nicotine can be absorbed into the body via inhalation, ingestion, skin contact and
through the mucous membranes [29], it is possible that the vapor from electronic cigarettes can
potentially cause secondary and tertiary environmental exposure to nicotine for those in the
area around e-cigarette users. Airborne concentrations of nicotine have been studied for both
regular and electronic cigarettes. Using a smoking machine connected directly to sampling
devices and a sample bag, McAuley et al. compared airborne concentrations of several
components of both nicotine cigarette smoke and e-cigarettes.[18] The authors reported
airborne nicotine concentrations ranged from 725 to 8770 nanograms (ng) per liter (equivalent
to 0.725 to 8.77 micrograms per cubic meter [μg/m3]), which were lower than those from regular
cigarettes, which ranged from 5.04 μg/m3 to 48.05 μg/m3.[18] Czogala et al. examined ecigarette vapors from three different brands and compared the components to those from
secondhand tobacco smoke through the use of an exposure chamber.[21] Though the level of
nicotine exposure varied by brand of e-cigarette, the authors reported that e-cigarettes were
observed to emit nicotine in concentrations ranging from 0.82 μg/m3 to 6.23 μg/m3 while the
average concentration of nicotine from tobacco cigarettes was 10 times higher.[21] Schober et
al. reported airborne concentrations of nicotine during a two-hour vaping session ranging from
0.6 to 4.6 μg/m3.[36]
OSHA regulates exposure to nicotine in the workplace to less than 0.5 mg/m3 (500 μg/m3) for
the industrial workplace, and the American Conference of Governmental Industrial Hygienists
publishes a Threshold Limit Value for nicotine at the same level for an eight-hour time-weighted
average (TWA).[37] However, ANSI/ASHRAE Standard 62.1-2013 – Ventilation for Acceptable
Indoor Air Quality (IAQ), applicable to office buildings, schools, larger multifamily housing, and
7
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many other spaces, cautions that the OSHA standards and ACGIH guidelines are intended to
limit worker exposure to injurious substances at levels that do not interfere with the industrial
work process and do not risk the workers’ health and safety. These standards and guidelines do
not attempt to eliminate all effects, such as unpleasant smells or mild irritation.[38] Therefore,
the target population and use of these standards and guidelines are different from those for the
populations of many public and commercial buildings.[38] Consequently, while the reported
airborne levels measured for nicotine from e-cigarettes in the chamber study by Czogala et
al.[21] and vaping session by Schober et al.[36] were at a fraction of the OSHA regulatory level,
there are other factors that need to be considered. OSHA standards are based on working with
nicotine occupationally, so they are not entirely applicable or appropriate for IAQ irritation,
nuisance, and exposure purposes.
A literature review for information on potential surface deposition of nicotine from e-cigarette use
(tertiary, or thirdhand, exposure) revealed that very little information is available. In February
2014, the Roswell Park Cancer Institute in Buffalo, N.Y., presented data from an unpublished
research project to the Society for Research on Nicotine and Tobacco in Washington state.
Researchers analyzed three brands of e-cigarettes filled with varying nicotine
concentrations.[39] The e-cigarettes were smoked, or vaped, in an exposure chamber, and the
resultant nicotine levels on five different surfaces of the smoking chamber were measured.[39]
The surfaces included glass, floors, walls, windows, wood, and metal. The researchers found
that three out of four experiments showed significant, yet varying, increases in nicotine found on
the five surfaces. The researchers concluded by stating that future research should “explore the
risks of exposure to carcinogens posed by thirdhand exposure from e-cigarettes.”[39] According
to Bloomberg School of Public Health Professor Dr. Patrick Breysse, in a pilot study conducted
by Johns Hopkins University, two of three surface samples collected in a vaping lounge had
detectable levels of nicotine (P. Breysse, personal communication, May 14, 2014).

Glycols and Glycerin
Propylene glycol, a chemical found in theatrical smoke, and vegetable glycerin are both used in
e-cigarettes as vehicles for the nicotine and the flavorings, and to create the “vapor” that is
emitted.[13,14,15] Analysis of various vaping solutions has revealed concentrations of
propylene glycol ranging from 60 percent to 90 percent, and up to 15 percent glycerin,[13,14,15]
although some vendors have reported mixtures of equal parts [40] and others substitute glycerin
and water for PG completely.[41] Many websites now supply custom e-liquids formulated the
way the user requests it, including such variables as flavors, nicotine concentrations, and
whether glycols or glycerin are used and in what concentrations. Users may purchase raw
materials and compound e-liquids themselves[42] with the help of numerous online
concentration calculators[43] or calculation applications available for mobile phones. While
propylene glycol has been used in other legitimate drug delivery methods, such as inhalers and
nebulizers, the frequency of use and exposure is expected to be much higher for electronic
cigarette users than for recognized medical uses.[16]
Concentrations of 1,2-propanediol (propylene glycol) in the range of 110 μg/m3 to 215 μg/m3 and
glycerine in the range of 59 μg/m3 to 81 μg/m3 were found in the gas phase of emissions during
an e-cigarette vaping study.[36] Another study reported airborne concentrations of PG ranging
from 2254 ng/l to 120,000 ng/l (2.25 mg/m3 to 120 mg/m3).[18]
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A generally recognized occupational guideline for airborne exposures to propylene glycol mists
and vapors is the AIHA® Workplace Environmental Exposure Level (WEEL), which
recommends a maximum eight-hour TWA for total vapor and aerosol of 50 parts per million
(ppm) (156 mg/m3);for aerosol alone the TWA is 10 mg/m3.[44] Exposures during theatrical fog
use are not expected to be near those levels.[44] However, in a study of the health effects of
theatrical fogs, it was determined that exposure to these fogs may contribute to both acute and
chronic health issues, such as asthma, wheezing, chest tightness, decreased lung function,
respiratory irritation, and airway obstruction.[45] Information shared among many vaping
websites includes the following information:
Some of the side effects experienced by people that use propylene glycol are muscle
pain, sore throat, and stronger smelling urine. These symptoms can all result from using
e-cigs that use propylene glycol-based e-liquid. Since PG is considered a humectant (it
collects moisture), your throat can become dry after use and potentially sore. It can also
result in an increase of lactic acid production by your body causing muscle aches that
occur more often than normal.[40]
In one case, the suspected cause of a patient’s development of exogenous lipoid pneumonia,
which is a rare form of pneumonia caused by inhalation or aspiration of a fatty substance, was
from recurrent exposure to glycerin-based oils in e-cigarette nicotine vapor.[46]
An unfortunate outcome of the presence of glycerin may be the presence of acrolein,
formaldehyde, and acetaldehyde in the vapor, which has been shown to form as a result of
heating or pyrolysis of glycerin.[47] This is a particular concern with second-generation (tank
type) and third-generation (rebuildable atomizer type) e-cigarettes with adjustable voltages, and
perhaps low-resistance coils as well. As-yet unpublished laboratory studies by Johnson and
Floyd have shown that the mass of aerosol produced during vaping increases dramatically with
the power of the device, which goes up as the square of voltage (power in watts = potential in
volts2/resistance in ohms). In experiments with a tank type (second generation) variable voltage
e-cigarette with a 3-ohm resistance coil, these researchers measured a 33-fold increase in fluid
mass vaporized with only a doubling of voltage from 3V to 6 V. (D. Johnson and E. Floyd,
personal communication, May 29, 2014). This suggests a geometrically increasing risk of toxic
effects as the devices gain power via stronger batteries, lower resistances, and adjustable
voltages.
Diethylene glycol, an impurity of PG, is also an organic compound of concern because it was
observed to be present in one of 18 refill cartridges evaluated by the FDA and has thus been
cited as a contaminant of concern by the FDA.[7,15,16,36,41] Toxicity studies with diethylene
glycol indicate that chronic inhalation of vapor, fog, or mist should be avoided, especially where
it is heated or used at elevated temperatures.[48] Because of its adverse effects on humans,
diethylene glycol is not allowed in food and drugs.[15] However, a review of 15 additional
studies of compounds associated with electronic cigarettes did not identify diethylene glycol to
be present.[16,41]

Flavorings
A review of several online suppliers and manufacturers of e-cigarette liquids revealed that an
extensive assortment of flavors is available. Flavor additives are often referred to as natural,
though further information is not provided about the composition or source of these additives.
9
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The most widely and readily available source of flavorings is for food products, so it can likely be
assumed that many manufacturers of flavored e-cigarette liquids are using flavoring products
intended for food ingestion.
The Flavor and Extract Manufacturers Association (FEMA) maintains an independent program
that evaluates the safety of substances for their intended use as flavor ingredients.[46] The
primary route to regulatory authority to use flavor ingredients in the United States is the FEMA
GRAS program. Some manufacturers of e-liquids use a wide variety of natural and artificial
flavoring agents, with the most readily available sources being those whose origins were
intended for inclusion as flavoring in food products. Research on some flavorings used in
tobacco products has revealed that benzaldehyde has been detected in cherry flavoring, methyl
anthranilate was detected in grape flavoring, and 1-hexanol was detected in apple flavoring.[50]
Some websites that sell premade e-liquid mixes are using manufacturing sources from outside
of the United States. FEMA has stated: “None of the primary safety assessment programs for
flavors, including the GRAS program sponsored by FEMA, evaluated flavor ingredients for use
in products other than human food. FEMA GRAS status for a flavor ingredient does not provide
regulatory authority to use the flavor ingredient in e-cigarettes in the U.S.”[49] Therefore, the
safety of the use of these flavorings in e-cigarettes has not been tested or approved. In addition,
the heating process and vaporization of these products in electronic cigarettes result in an
inhalation of aerosol, rather than ingestion. Further, no research is known to have been
conducted on the pyrolyzation products of any of the flavorings, which may be occurring at
higher vaping powers. Therefore, a compound that may be GRAS when ingested is no longer
automatically safe for inhalation.
A clear example of this problem is the use of diacetyl (butanedione or butane-2,3-dione) as a
buttery flavoring for popcorn, baked goods, and liquor. Numerous research papers have been
published and lawsuits have been filed in the past decade regarding employees in several
factories that manufacture or use artificial butter flavoring who have been diagnosed with
bronchiolitis obliterans, a rare and very serious disease of the lungs.[51]
Diacetyl is an example of a flavoring that is approved for ingestion but has potential health
effects when volatilized and inhaled. In November 2010, the state of California passed
legislation relating to employee exposure, physical examinations, and personal protective
equipment when working with diacetyl in the workplace because of the potential health concerns
associated with inhaling the aerosolized flavoring.[52] Due to a lack of strong quality control or
labeling requirements, and the lack of research on domestic and imported e-liquids, it is
unknown at this time how many other GRAS (or non-GRAS) flavoring agents may fall into this
same ingestion vs. inhalation quandary.

Volatile Organic Compounds
A number of published studies have been conducted worldwide examining, among other things,
the presence of various VOCs in e-cigarette vapors. One German study compared secondhand
emissions, including VOCs, of e-cigarettes and conventional cigarettes.[17] Researchers tested
three different brands of e-cigarettes loaded with three different liquids, two containing nicotine
and one that is nicotine free. The authors stated that continuous monitoring of the e-cigarette
vapor showed only a slight increase in formaldehyde concentrations, which the researchers
theorized may have actually been caused by the test subject instead of the e-cigarettes.[17]
Other indoor pollutants of special interest, such as benzene, were detected only during the
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tobacco smoking experiment. It should be noted, however, that the test subject took only six
puffs from each cigarette, with a 60-second delay between puffs, which may not be
representative of normal vaping behavior.[17]
Another German study, using commercially available e-cigarettes and three different liquids
(both with and without nicotine), reported that formaldehyde, benzene, and the pyrolysis
products acrolein and acetone did not exceed background concentrations.[36] Indoor
concentrations of vanillin and benzylalcohol were only slightly increased compared with control
values. However, PAH concentrations increased on average by 20 percent over background
levels.[36]
A Polish study of three popular e-cigarette brands with nicotine containing liquid reported that
only toluene was detected in the exposure chamber after e-cigarette usage, and that the levels
were not statistically above background concentrations.[21] The authors also studied emissions
from regular cigarettes and compared them to those from the e-cigarettes. They noted that
smoking as few as two tobacco cigarettes significantly increased the airborne concentration of
toluene, ethylbenzene, m,p-xylene, and o-xylene, and that for toluene, the average
concentration after smoking tobacco cigarettes was 3.5-fold higher than after using ecigarettes.[21]
Another Polish study examined the vapor generated by 12 brands of e-cigarettes filled with
nicotine-containing liquid analyzed for 11 common VOCs and 15 carbonyl-containing VOCs. Of
the 11 common VOCs, only toluene and m,p-xylene were identified in the vapor generated from
the e-cigarettes, but they were found in almost all of the e-cigarettes tested.[47] However, the
researchers also noted that the levels of m,p-xylene detected in the vapor were similar to those
found in the blank samples. Of the 15 carbonyl-containing VOCs, formaldehyde, acetaldehyde,
o-methylbenzaldehyde, and acrolein were observed in nearly all e-cigarettes tested. [47]
A U.S. study examining emissions from four different high-nicotine-content e-liquids vaporized
by generic two-piece e-cigarettes, as well as from conventional cigarettes, found detectable
levels of ethylbenzene, benzene, toluene, and m,p-xylenes in the vapor.[18] However, the levels
in the tobacco smoke were orders of magnitude higher than those found in the e-cigarette
vapor.
A Japanese study of 13 e-cigarette brands (363 e-cigarettes in total) found that nine of the
brands generated detectable airborne levels of various carbonyl compounds, including
formaldehyde (concentrations up to 61 mg/m3), acetaldehyde (concentrations up to 48 mg/m3),
acrolein (concentrations up to 34 mg/m3), and propanal (concentrations up to 27 mg/m3).[53]
The authors noted that there were very large variations in the carbonyl concentrations, not only
among the different brands but also among individual e-cigarettes from the same brand. They
theorized that the compounds were generated as a result of the e-liquids incidentally touching
the heated wiring in the atomizers.[53]

Metal and Silica Particles
Electronic cigarettes are designed with metal components that have also been found in the
aerosol. Resistive wire filaments (nickel-chromium or other metals) are used to heat the wick
and evaporate the e-liquid.[19] Often these resistive wires are coupled to nonresistive
extensions of copper wire (sometimes coated with silver), and often tin solder joints connect the
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wires to each other and to the air tube and mouthpiece.[19] Fibers found in some cartomizers
(atomizers, heating coils) had copper deposits, and both tin particles and tin whiskers were
found in some cartridge fluid.[19] Aerosols generated from electronic cigarettes have been
found to contain tin, silver, iron, nickel, aluminum, sodium, copper, magnesium, lead, chromium,
manganese, potassium, zinc, silicates, and nanoparticles of tin, chromium, and nickel.[19] The
silicates appear to come from fiber glass wicks used in the product and are not expected to be
crystalline silica.[19] Goniewicz et al. also found cadmium to be present in the aerosol
generated from some, but not all, e-cigarette products.[47]
One study found lead and chromium concentrations in electronic cigarette aerosols within the
same range as conventional cigarettes (0.017 μg/10 puffs for lead and 0.007 ug/10 puffs for
chromium).[19] Airborne nickel was found to be in higher concentrations in e-cigarette vapor
than in conventional cigarette smoke (0.005 μg/10 puffs vs. the highest concentration of 0.0014
μg/10 puffs for conventional cigarettes).[19] Overall, the researchers found concentrations of
nine different metals to be higher than or equal to the range of concentrations found in
conventional cigarette smoke.[19] Another study found airborne aluminum concentrations
increased from the approximately 0.20 μg/m3 background concentration to approximately
0.48μg/m3 during e-cigarette vaping sessions.[36]
While the airborne exposure for all metals during vaping has not been well-defined in terms of
dose or concentration (in mg/m3 or ppm), all of the elements found in the aerosol have the
potential to adversely affect the respiratory system; some can affect reproduction and
development (e.g., lead); and some are considered carcinogens or “reasonably anticipated to
be human carcinogens” (e.g., nickel and lead).[19,54,55] Lead, nickel, and chromium are also
on FDA’s “harmful and potentially harmful chemicals” list.[19]
Williams et al. evaluated the cytotoxicity of electronic cigarette fluids, with and without tin
particles, and found that the fluids with tin particles were observed to be cytotoxic in assays
using human pulmonary fibroblasts, but the fluids without tin particles were not.[19] The
presence of tin in the fluid appeared to be dependent on the quality of the wire soldering and the
extent of presale use or testing performed on the units, as several of the “new” units evaluated
showed signs of use prior to purchase.[19]

Ultrafine Particulates
Research over the last two decades has demonstrated that exposure to airborne fine and
ultrafine particulate matter results in a variety of adverse health effects. Wichmann et al. found
significant associations of elevated cardiovascular and respiratory disease mortality with various
fine (and ultrafine) particle indices.[56] In his study, significant associations were found between
mortality and ultrafine particle number concentration, ultrafine particle mass concentration, and
fine-particle mass concentration.[56]
The particulate size distribution and composition of tobacco smoke is well-documented and will
be reviewed here only as a comparison to e-cigarettes. Schripp conducted studies in an 8 m3
chamber to evaluate the size distribution of submicron particulates from both tobacco smoke
and e-cigarettes.[17] The traditional cigarette produced a log-normal distribution around a mean
size of 100 nanometers (nm) in diameter, with a peak concentration of 4.0 × 104 particles/cm3,
while the e-cigarette were found to produce a size distribution around a mean of 35 nm in
diameter with a concentration 2.0 × 103 particles/cm3.[17] Although the concentration of
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particulates from the tobacco smoke was found to be an order of magnitude greater than the
electronic cigarettes (when generated under the same conditions), these findings are significant
because both the particulate size and concentration levels are a concern.
Schripp also examined the size distribution as the e-cigarette particles aged. The aging process
at different temperatures suggests that exhaled e-cigarette vapor can result in passive exposure
as well a shift in the particle size, where peak size shifted to smaller sizes, from about 180 nm at
23oC to 60 nm and 45 nm at elevated temperatures (37°C and 50oC respectively).[17] However,
e-cigarettes release particles only during exhalation, whereas regular cigarettes emit particles
continuously during combustion via side-stream smoke. The overall conclusions presented by
Schripp et al. were that vaping will introduce particles into the indoor environment that are of
concern from both a size and concentration standpoint but are substantially less than tobacco
cigarettes.[17]
In another study of e-cigarette emissions, Ingebrethsen reported even higher particulate
concentrations and larger average particle masses. Particle diameters of average mass in the
250 nm to 450 nm range, and a total particle count in the 106 particles/cm3 range, were reported
for aerosols from e-cigarettes measured with an electrical mobility analyzer.[57] These
measurements were reported to be similar to those observed from tobacco cigarettes. Yet
another study by Zhang et al. reported e-cigarette particle size between 10 and 1000 nm, with
an average of 400 nm.[58] Based on particle size, the authors expect deposition in the human
lung similar to that of tobacco cigarette smoke.[58]
Research shows that ultrafine particles form from supersaturated 1,2-propanediol vapor, which
can be deposited in the lung.[36] Schober et al. found that airborne PM2.5 concentration during
vaping sessions with e-cigarette users were approximately 373 µg/m3, with the highest levels
(514 µg/m3) found during vaping sessions with no nicotine in the vaping solution.[36] These
results reflect airborne concentrations in a fairly large room due to exhaled vapor. Therefore,
these results relate primarily to the potential for secondhand exposures.
Another study, using a device that simulated vaping during a three-minute session, reported
PM2.5 concentrations of 43 µg/m3 after three minutes.[54] People who have frequently been
exposed to theatrical fogs containing ultrafine particles of propylene glycol are more likely to
suffer from respiratory, throat, and nose irritations than do unexposed people, suggesting that ecigarettes may foster similar health effects.[59] Therefore, while these limited results vary, the
generation of airborne ultrafine particles from e-cigarettes is a potential indoor air quality issue.
As a measure of impact from inhaling ultrafine particles from e-cigarettes, Marini et al. examined
the acute effects of electronic and tobacco cigarettes on exhaled nitric oxide (eNO).[60] Exhaled
nitric oxide has been used as a noninvasive method to measure inflammation of the lung after
exposure to pollutants. Marini applied eNO tests to a group of 25 volunteers who use tobacco,
e-cigarettes with nicotine, and nicotine-free e-cigarettes.[60] The eNO tests were applied before
and after smoking/vaping to allow for the comparison in the changes in eNO for individuals.[60]
The average total particle number concentration peak was found to range from 3.1 × 109/cm3 for
conventional cigarettes to 5.1 × 109/cm3 for e-cigarettes with nicotine.[60]
Oddly, the e-cigarette particulate emissions were found to be 1.5 times higher than those from
traditional cigarettes, a stark contrast to previous studies.[60] However, the main focus of this
article was to understand changes in eNO levels from e-cigarettes with and without nicotine.
The mean eNO changes measured after each vaping test were found to be 3.2 parts per billion
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(ppb), 2.7 ppb, and 2.8 ppb for electronic cigarettes without nicotine, with nicotine, and for
conventional cigarettes, respectively.[60] The control sessions were found to have negligible
change in eNO.[60] Hence, the short-term respiratory effect found in this study was that ecigarettes, as well as traditional tobacco cigarettes, led to immediate reduction in eNO,
suggesting inflammation of the airways.
Floyd et al. recently compared vaping aerosols from a second-generation adjustable voltage
tank style e-cigarette to tobacco cigarette smoke aerosol (D. Johnson and E. Floyd, personal
communication, June 12, 2014). They measured particle size distributions over a broad range,
from 16 nm to 20 µm, and found that less than 40 percent of both the e-cigarette aerosol and
tobacco-smoke aerosol particle mass was comprised of particles less than 1 µm in diameter.
They also observed a 32-fold increase in vaporized e-fluid when voltage was increased from
3.15 V to 5.81 V, demonstrating the potential for newer generation, more powerful devices to
produce much higher concentration aerosols. The higher heating coil temperatures associated
with these high-power devices also pose the risk of chemical changes in the e-fluid, which is
suspected to produce aldehydes and carbonyls.[61,62]
The work completed to date on aerosols generated from e-cigarettes suggests that they present
a new source of aerosols in indoor environments. While the aerosol number concentration is
smaller than that from traditional cigarettes, the smaller size distribution of e-cigarette aerosols
may result in different deposition locations within the lung. Because of the relatively new
widespread use of e-cigarettes, the relationship between exposure and any health effects is still
evolving. However, the evidence of health effects from a number of authors linking ultrafine
particles to respiratory and cardiovascular disease clearly indicates a potential health concern.

Tobacco-specific Nitrosamines
Tobacco-specific nitrosamines (TSNAs) have been reported to be found in trace levels in
electronic cigarettes in at least two studies, but are found in concentrations well below TSNA
levels in regular cigarettes.[16,47] However, residual nicotine from tobacco smoke has been
shown to react with ambient nitrous acid to form TSNAs over time, therefore increasing the
overall potential exposure.[63] Some TSNAs are known human carcinogens and are suspected
to contribute to the cancer burden of smokers.[64]

Nut Allergens
An area about which knowledge is currently lacking is the presence of nut allergens that may be
found in e-cigarette liquids. On the General Frequently Asked Questions (FAQ) page of e-liquid
supplier Johnson Creek’s website, a question was posted from a consumer worried about
allergy to nuts and the use of e-liquids. The company’s website response was:
If you have an allergy to nuts, we recommend that you NOT use Johnson Creek Original
Smoke Juice. It is possible that some of our flavors may have nut-based ingredients, or
may be produced in a facility that processes nuts.[65]
The presence or potential presence of nut allergens within e-cigarette liquid obviously poses a
concern for users with nut allergies. What is currently unknown is whether a nut allergen
contained in a flavored e-liquid can become airborne during e-cigarette use and pose an
airborne exposure risk for sensitive individuals nearby. This is an area where research is
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warranted, especially with the implication of risk for individuals with nut allergies exposed to
secondhand e-cigarette vapor. This identifies another area needing research: If a nut allergen
becomes airborne, could this allergen then deposit onto surfaces in the area of use and then
pose a dermal risk for allergic individuals – a thirdhand exposure?

Other Constituents
As previously stated, there is evidence that the vaporization technology used in e-cigarettes has
been employed to deliver other drugs such as tadalifil (a drug used for erectile dysfunction) and
rimonabant (a weight-loss aid)[13] and that this technology may prove beneficial for specific
prescription drug mobilization. However, as the e-cigarette technology has been described in
detail in the public domain and numerous online special interest groups (SIGs), hobbyists and
dedicated e-cigarette users and supporters are able to purchase individual components to
manufacture their own e-cigarette hardware configurations.
As of May 2014, this subject review has identified numerous websites that sell components for
the elution of plant material extracts into the cigarette delivery system.[66] In short, one may
now deliver liquid extracts of medical marijuana, hashish, and crack cocaine[67,68] into the
vaping system with allegedly no odor detection by other room occupants.

Overall Health Effects Associated with E-cigarettes
Currently, there are limited published studies that evaluate the potential hazardous effects of the
natural and/or synthetic chemicals used in e-cigarettes. Overall, the literature to date indicates
that there are potential health effects reported for both users and those exposed secondhand.
E-cigarette users in online forums self-reported a variety of health symptoms that they associate
with using e-cigarettes, including mouth and throat irritation, cough, nausea, changes in heart
rhythm, and dizziness.[69] Although studies have shown that consumption of e-cigarettes did
not show changes in blood pressure for participants, a review of these forums revealed that
blood pressure changes were reported by 3.5 percent of e-cigarette users.[69] Some users also
reported experiencing increased heart rates, although some scientific studies have shown that
heart rate did not increase during the use of prepackaged e-cigarettes.[70]
Bahl et al. studied the cytotoxicity of 35 samples of e-cigarette refill fluids using human
embryonic and adult cells.[71] Twenty-seven of the 35 refill samples were moderately to highly
toxic to the embryonic cells, with less severe effects on the adult cells.[71] The observed
cytotoxicity was not attributable to the nicotine present in the fluids but was correlated with the
number and concentration of chemicals used to flavor the fluids.[71] Their research indicated
that the observed cytotoxic effects could potentially translate into embryonic loss or
developmental defects during pregnancy.[71] Additional preliminary information presented by
Cressey indicates that human bronchial cells exposed to high levels of e-cigarette vapor in vitro
expressed gene patterns similar to human bronchial cells exposed to tobacco smoke in
vitro.[72] These researchers state that, while e-cigarettes may be safer than tobacco,
“preliminary studies suggest that they may not be benign.”[72]
Overall airway resistance and lung function associated with e-cigarette use has been studied
with varying results. Flouris et al. reported that neither a brief session of active e-cigarette
smoking, nor a one-hour duration of passive e-cigarette smoking, resulted in any significant
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interference with lung function measured using forced vital capacity (FVC), forced expiratory
volume in one second (FEV1), FEV1/FVC ratio, peak expiratory flow (PEF), or forced expiratory
flow in the middle 50 percent of FVC (FEF25-75).[14] However, a different study that evaluated
the fraction of exhaled nitric oxide (FeNO), a marker of bronchial inflammation, along with
FEV1, FVC, FEV1%, PEF, maximal expiratory flow (MEF) at 25 percent, 50 percent, and 75
percent of vital capacity, and total respiratory resistance discovered that five minutes of ecigarette use was sufficient to lead to an increase in lung flow resistance and a decrease of
FeNO concentrations, which is a marker for oxidative stress in the lung.[5]
However, another study found a rise of FeNO in users of nicotine containing e-cigarettes, but
not in users of non-nicotine-containing e-cigarettes.[36] A limited Greek study found that ecigarette users experienced an instant increase in airway resistance that lasted for
approximately 10 minutes, using a spirometry test and other diagnostic procedures.[4] Smokers
experienced an airway resistance from 176 percent (mean average) to 220 percent, while
nonsmokers experienced an airway resistance from 182 percent to 206 percent.[4] Long-term
exposures were not evaluated in any of these studies.
Early research showed that, per puff, nicotine absorption is lower for e-cigarettes than for
tobacco cigarettes.[14] One study reported that e-cigarette users have, in general,
approximately 10 percent of the nicotine concentration in their blood plasma as compared to
tobacco cigarette users,[69] while others have shown no significant changes in plasma nicotine
as a result of the use of some prepackaged products.[20] These values may change with the
increased use of personal mixes of liquids where the user can control the nicotine
concentration.
Flouris et al. found that while active and passive tobacco smokers experience an increased
white blood cell count, lymphocyte count, and granulocyte count, active and passive e-cigarette
smokers do not.[73] Farsalinos et al. reported that there were no acute adverse effects on
cardiac function reported in smokers or nonsmokers using e-cigarettes.[74] This is consistent
with reports that cardiovascular disease from tobacco use is likely related to the combustion
byproducts of tobacco smoke.[71]

Other Health and Safety Issues
Because some styles of e-cigarettes resemble regular cigarettes, allowing the use of ecigarettes in smoke-free places may lead people to believe that no ban on smoking in that
location exists and, as a result, to light up conventional cigarettes.[75] Some research shows
that for smokers, the observation of others smoking increases the craving and potential for
ultimate consumption of cigarettes.[76] Therefore, careful consideration should be given to
allowing the use of e-cigarettes without restriction in the workplace, as it may induce others
who are attempting abstinence to desire to smoke as well.
Moreover, recent media attention has brought additional safety issues, including child safety
and poisonings, battery explosions, and the potential for the vapor to set off smoke alarms. The
American Association of Poison Control Centers reported that poison control centers have
reported an increase in emergency calls regarding exposures to e-cigarette devices and liquid
nicotine, with more than half of the exposures occurring in children under the age of six. [77]
Although many e-cigarette vials have safety caps, the caps are currently not required by law.
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Several incidents of fires and explosions have been reported from the lithium-ion batteries used
to charge e-cigarettes. The most common causes of fires have been using incorrect chargers or
over-tightening of the screwed connection to the charger, which can damage the battery cells
and lead to overheating.[78] Unfortunately, many lithium–ion batteries used in e-cigarettes do
not have overcurrent or overcharge protection, so if they are left charging, the coil can overheat
and cause the battery to explode.[78]
One vaper demonstrated online that it is possible to set off a smoke alarm using an ecigarette.[79] However, whether the vapor can or will set off smoke detectors appears to be
dependent on the situation and the type of smoke alarm.

Current Regulatory and Health Agency Statements
E-cigarettes are enjoying some support from those who back their use as a way to reduce harm
from smoking traditional tobacco cigarettes. Dr. Richard Carmona, the U.S. Surgeon General
during the George W. Bush presidency and who was responsible for a 2006 report on
secondhand smoke that helped to ban smoking in restaurants and bars, joined the board of
directors of an e-cigarette manufacturer in March 2012.[80]
Carmona advocates that e-cigarettes reduce the risk for smokers and recipients of secondhand
smoke by eliminating combustion byproducts, many of which are carcinogenic.[80] However, he
notes that he joined the board on four conditions: (1) that the company seek FDA regulation; (2)
that the company conduct research and openly publish results regardless of real or potential
financial impact; (3) that the company may not use his name or previous position to promote its
e-cigarettes; and (4) that the company not market e-cigarettes to children.[80] His idea is that
the company will research effects of secondhand vapor and how well e-cigarettes help people
totally wean themselves from both tobacco products and e-cigarettes.[80]
WHO has recommended that consumers be strongly advised not to use electronic nicotine
delivery systems, including e-cigarettes, until they are deemed safe and effective and of
acceptable quality by a competent national regulatory body.[8] WHO noted that the safety of the
devices has not been scientifically demonstrated.[8] While WHO discourages the use of ecigarettes, it has not yet taken a position on whether they should be banned. It has been
reported that WHO is planning on regulating e-cigarettes in the same way as traditional tobacco
products.[81] E-cigarettes would be classified as tobacco under the Framework Convention on
Tobacco Control, which is a WHO treaty that obliges governments to curtail smoking rates
around the globe.[81] However, as of the publication date of this white paper, WHO has made
no official statement or position on this matter.
The regulatory status of e-cigarettes is constantly changing. Although these products may use
some ingredients derived from tobacco, such as nicotine, other ingredients are clearly not
related in any way to tobacco products. The FDA currently regulates only e-cigarettes that are
marketed for therapeutic purposes.[82] However, the FDA has proposed a rule extending its
tobacco product authorities to include other products like e-cigarettes.[83] The FDA has
previously taken action against manufacturers of e-cigarettes, claiming that they violated good
manufacturing practices and made unsubstantiated drug claims.[84] However, manufacturers
sued the FDA, claiming that e-cigarettes should be regulated as tobacco products, and not as
drugs.[84] Beginning in 2016, Great Britain will start to regulate e-cigarettes as a
nonprescription medicine.[85] Other countries, such as Brazil, Norway, and Singapore, have
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banned the use of e-cigarettes.[85]
Several agencies and organizations have adopted the approach that e-cigarettes are equivalent
to traditional cigarettes, or that the hazards are unknown and, therefore, are subject to the
current bans on cigarette advertising; restrictions on sales; and bans on use in public places,
transportation facilities, and restaurants and bars. For example, the states of Arkansas, New
Jersey, North Dakota, and Utah[86]; and the cities of Los Angeles, New York, Washington, DC,
Chicago,[87] and Duluth, Minn.,[88] have included e-cigarettes in indoor smoking regulations.
Mississippi’s DeSoto County has added e-cigarettes to the local smoking ban in government
buildings,[86] and the governor of Oklahoma has banned the use of any electronic cigarette or
vaping device on any properties owned, leased, or contracted for use by the state.[89] Many
other states and municipalities are discussing similar legislation or bans.
Although traditional cigarettes are currently taxed heavily in the United States, e-cigarettes are
not uniformly subject to tobacco taxes if no tobacco-derived products are involved, which makes
them relatively less expensive than traditional cigarettes. The nontaxed cost of e-cigarettes can
be viewed as encouragement of the use of e-cigarettes.
Several states have included e-cigarettes under tobacco tax requirements, though they are
currently not subject to federal tobacco taxes. For example, Minnesota has modified the
definition of “tobacco products” to include terminology that allows e-cigarettes to be taxed as
tobacco products.[84] However, careful review of the wording of each state’s tobacco laws
would be required to extend purchasing limitations of e-cigarettes as a tobacco product to
minors.[84] Restrictions on advertising to minors and bans on Internet sales or sales to minors
have either been enacted, or are being planned, by several organizations including 38
states[90] and the FDA.[91]
Regarding whether the use of e-cigarettes is allowed or banned on commercial aircraft in the
United States, the regulatory status is not clear. During a hearing in 2010 before the Senate
Committee on Commerce, Science and Transportation, Susan Kurland, Assistant Secretary for
Aviation and International Affairs, U.S. Department of Transportation (DOT), when asked
whether the agency planned to explicitly ban the use of electronic cigarettes on commercial
airplanes, stated that the smoking of e-cigarettes was already banned.[92] However, some
question that statement, noting that only “tobacco products” are banned on certain scheduled air
carrier flights in Part 252 of Title 14 of the Code of Federal Regulations, “Smoking Aboard
Aircraft.” [93]
In 2011, DOT proposed amending its existing airline smoking rule to explicitly ban the use of ecigarettes on all aircraft in scheduled passenger interstate, intrastate, and foreign air
transportation.[94] In their proposal DOT cited its specific statutory authority to prohibit
smoking, under Section 41706 of the Title 49 of the United States Code, on “Prohibitions
against smoking on scheduled flights” which does not specifically mention tobacco or explicitly
limits its scope to smoking of tobacco products. [95] DOT also based its proposal on its general
duty statutory authority that, regarding “interstate air transportation, [a]n air carrier shall provide
safe and adequate interstate air transportation.”[96] A group of organizations, including the
American Lung Association, the American Heart Association, and the Cancer Action Network,
sent a letter of support for DOT’s proposal to prohibit e-cigarettes on all commercial aircraft. The
reasons provided included that health consequences were unknown and that allowing the use
would create significant confusion for passengers, along with enforcement challenges for airline
18

American Industrial Hygiene Association®
White Paper: Electronic Cigarettes in the Indoor Environment

personnel.[97] However, to date a ban has not been issued. In addition, the Federal Aviation
Administration has not promulgated a ban and has left it to the airlines to set their own policies
in regard to whether e-cigarettes are allowed on flights.
Major U.S. airlines have amended their no-smoking policies to specifically include e-cigarettes.
For example, United Airlines’ smoking policy states: “Smoking (including use of electronic
simulated smoking materials and smokeless cigarettes) is not permitted on any flights operated
by UA.”[98] However, not all airline smoking policies are completely clear about e-cigarettes.
For example, JetBlue’s Contract of Carriage’s smoking policy simply states: “Smoking aboard
the aircraft is prohibited in accordance with Federal Law”[99], but the help section of JetBlue’s
website states, “JetBlue does not allow the use of [e-cigarettes] on any of its flights. It is
considered a nuisance item as small amounts of vapor are expelled from the cigarette.”[100]
Even with clear prohibition of e-cigarettes by certain airlines, some e-cigarette proponents have
posted recommended strategies for being allowed to use the device, suggesting that it be called
a “nicotine inhaler” and insisting that the use of the device is not covered by smoking bans on
airplanes.[101]
Other transit systems, such as commuter rail lines, subway systems, and bus services, have
also created issues with ambiguity over e-cigarette usage by only referencing federal law that
smoking (of tobacco) is banned. Amtrak has had a no-smoking policy since 2008 that
specifically includes e-cigarettes both on trains and in stations.[102] Many transit entities have
updated their policies to specifically include e-cigarettes, such as the New York City-area
Metropolitan Transit Authority, operator of the Long Island Rail Road and Metro-North Railroad,
which updated its policy in the 2013.[103] The Los Angeles County Metropolitan Transportation
Authority amended its policy in March 2014 to prohibit vaping.[104]
A trade magazine reported that, as of April 2014, at least six additional transit-rail agencies –
Caltrain, Chicago Transit Authority, Dallas Area Rapid Transit, Metropolitan Atlanta Rapid
Transit Authority, Tri-County Metropolitan Transportation District of Oregon, and Virginia
Railway Express – had adopted e-cigarette restrictions.[105] Regarding private-sector bus
companies, the Megabus policy states: “Smoking, including the use of electronic simulated
smoking materials, e-cigarettes, and smokeless cigarettes, is prohibited in our buses”[106];
however, the BoltBus policy simply states that “Smoking is prohibited aboard the bus in
accordance with Federal law”[107] and the policy for Greyhound states only that “Smoking is
prohibited.”[108]
To summarize, there is currently no federal law or regulation that explicitly bans the use of ecigarettes on U.S. airplanes, railroads, buses, or other modes of transportation. For
organizations and businesses that have smoking bans, especially those required by law, it
would be advisable for them to update their bans to specifically include e-cigarettes in order to
eliminate potential confusion among patrons as well as employees charged with enforcing those
bans.

Key Data Gaps and Uncertainties
There are several key data gaps and areas of uncertainty that hinder a more quantitative
assessment of health risks related to e-cigarettes at this time. These include:
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•

Quality control is lacking with regard to product constituents. (Manufacturers may not
disclose all of the chemical ingredients used in their products, nor, other than nicotine,
their amounts.)

•

Because many users mix their own blends and there are so many different types of
devices, what may be studied in the lab may not reflect actual exposures during use.

•

There is limited data on chemical emissions/exposures (especially among bystanders
and in confined indoor settings).

•

There is limited information on dose-response relationships for many constituents (such
as short- or long-term health effects associated with low-level exposures).

•

Established safety levels (occupational vs. environmental) are lacking.

•

At this time, there is no clear understanding of how much liquid is vaped by a user or a
population of users in a given day in comparison to how many cigarettes are smoked in
a day.[106] Variations in vaping habits, variable liquid strength, and uncertain overall
daily vaping duration make any scientific conclusions about the vaping population
tenuous at best.

Note that these issues are related only to an assessment of human health risks. They do not
incorporate other potentially important factors, such as public risk perceptions, risk management
options/control measures (e.g., ventilation), and nicotine dependence.
As the scientific community attempts to determine the inhalation health effects of the primary
components of e-cigarettes, current literature reveals little about the potential synergistic effects
of the main chemical components and of the numerous flavoring additives used. Additionally,
there is a dearth of information about the synergistic effects from e-cigarette contents and other
environmental contaminants.

Health and Sustainability Considerations
Many groups are affected either directly or indirectly by e-cigarettes. The type and magnitude of
the effects are dependent on which group is being evaluated. Groups of interest include current
smokers, former smokers, adults who never smoked, middle and high school students, children,
pregnant women, workers, the public, and individuals with compromised health (e.g.,
immunocompromised, heart disease, and lung disease). Discussions in the general literature,
and even in the scientific literature, often evaluate these groups indiscriminately.
For smokers, vaping is less toxic than smoking because the particulates and harmful toxicants
generated by the burning process are significantly reduced or eliminated. On its surface, this is
the only group that clearly benefits from e-cigarettes. For adults who are not current smokers or
who have never smoked, vaping clearly introduces toxicants including nicotine, flavorings, and
vehicle compounds, and their thermal degradation products.
Although the health effects to vapers may not be as great as those associated with traditional
smoking, they are greater than not vaping at all. Nicotine itself raises blood pressure, increases
heart rate, and is highly addictive. The flavorings used are often considered GRAS as food
additives, but these chemicals are inhaled during vaping, which obviously changes the route of
exposure. There is little or no information about the health effects of various food additives that
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are inhaled rather than ingested. For example, diacetyl is safe when ingested on popcorn, but it
potentially causes severe lung problems when inhaled during the manufacturing process.[51]
If the only individual affected by using e-cigarettes were the vaper, the discussion could end
here. That is not, however, the case. Similar to secondhand smoke, the ingredients exhaled by
the vaper include nicotine, metals, flavorings, and glycol that accumulate in the ambient air.
Recipients of secondhand vapor have not chosen to – many, in fact, have explicitly chosen not
to – use e-cigarettes. The exposure to secondhand vapor, just like secondhand smoke, raises
issues of involuntary exposure and competing rights. This is even more critical for groups that
may be, and probably are, more susceptible to adverse effects of secondhand vapor, including
children, pregnant women, and people with already compromised health, some of whom may
have limited ability to leave the spaces in which vaping occurs or has occurred.
The question of scale must also be considered. When secondhand vapor is evaluated, the scale
of the vaping must be included. This would include the volume of the space (size of the room),
number and type of e-cigarettes in use, the length of time in use, and the ventilation rate. For
example, ASHRAE has developed standards for ventilation rates to maintain indoor air quality in
general, and for smoking rooms in particular.[38]
Even with the ASHRAE standards, smoking rooms still have the potential for elevated levels of
toxicants from traditional tobacco products. In addition, the implementation of these ASHRAE
standards is not without cost. Measurements and evaluation cost time and money. The health
effects to individuals exposed before adequate standards are developed and implemented are
another cost.
Lastly, health effects that occur throughout the life cycle of an e-cigarette should be considered.
The health effects incurred by workers during the extraction of metals; the manufacture of
nicotine, flavorings, plastics, and batteries; and the health effects costs to package and
distribute e-cigarettes should be evaluated.
Sustainability requires an evaluation of social and economic aspects as well as health and
environmental effects. Advertising is a large component of the social acceptability of ecigarettes. Advertising promoted a positive social image of traditional cigarettes during the mid20th century. If e-cigarettes are perceived as being used by individuals whom society admires
(e.g., movie stars and athletes), their social acceptance will likely be assured. Advertising aimed
at high school students and young adults is particularly effective. Once e-cigarettes are socially
acceptable, the addictiveness of nicotine will provide a continued user group.
No doubt some individuals and businesses will profit from the development of an e-cigarette
industry, and a few might become quite wealthy. There are several economic costs, however,
that must also be evaluated. If e-cigarettes are not regulated in public places, contaminants
produced by them in the ambient air may keep customers away. At this point, most Americans
would not want to be an airplane passenger or be eating in a restaurant where traditional
cigarette smoking is freely permissible. If e-cigarettes are not regulated in workplaces, the real
and/or perceived effects will likely result in lost productivity, comparable to the lost productivity
associated with poor indoor environmental quality. Any increased health care costs associated
with the use of e-cigarettes, especially when health care costs are already enormous, must be
factored into overall national and global economies.
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Quantitative health risk assessment and the setting of exposure limits are useful in
some situations, such as occupational exposure control and environmental cleanup
projects.[110] Other types of risk assessment may be more useful in evaluating e-cigarettes,
such as a risk assessment methodology that looks at the costs and benefits of using a product
and then compares them to the costs and benefits of not using the product. In the case of ecigarettes, the only group that may benefit from their use consists of people who already smoke
and who may want to reduce their exposure to combustion byproducts. For other groups,
however, there are no benefits and there may be health risks. The health consequences of
secondhand exposure to nicotine and other substances may be imposed involuntarily on
vulnerable populations, such as children, pregnant women, and people with cardiovascular
and/or lung conditions.
Health effects that occur throughout the life cycle of the e-cigarette should also be considered.
Sustainability evaluations involve life cycle analyses that evaluate costs associated with
extraction, manufacturing, delivery, use and disposal of e-cigarettes. The health effects incurred
by workers during the extraction of metals, the manufacture of nicotine, flavorings, plastics, and
batteries, as well as the health effects costs to package and distribute e-cigarettes, should be
evaluated. Metals used in e-cigarettes and the batteries to run them are mined by workers
exposed to dust and other hazards. Also, inhalation and musculoskeletal health effects are
associated with the manufacture of plastics, nicotine, and flavorings used in e-cigarettes.
End-of-useful-life considerations for e-cigarettes should also be done before mass production
begins. Considerations should include battery recycling and/or reuse, and how the plastic used
in the cigarette itself will be recycled or reused, in order to reduce the environmental impact of
disposing of these e-cigarette components.

Conclusions and Recommendations
Given this review of available information, the existing research does not appear to warrant the
conclusion that e-cigarettes are “safe” in absolute terms. Although they may provide a “safer”
alternative to tobacco cigarettes for the vaper, these products emit airborne contaminants that
may be inhaled by both the user and those in the vicinity of vaping. Many of the data sources
reviewed confirm that e-cigarettes are not emission-free and that their pollutants could be of
health concern for users and those who are exposed secondhand. Therefore, e-cigarettes
should be considered a source of VOCs and particulates in the indoor environment that have
not been thoroughly characterized or evaluated for safety.
Multiple scientific reports express the need for more research. Much can be learned, however,
from critically evaluating what we already know. Clearly, e-cigarettes lack the combustion
products produced by smoking tobacco, many of which are associated with cancer
development. Although nicotine may not cause cancer, it is associated with other adverse
physiological effects. In addition, the other components in e-cigarettes may not be benign,
particularly when they are inhaled rather than ingested.
Some areas that need further research include:
1. Health effects from inhaling e-cigarette flavorings and other ingredients that are
reported to be generally recognized as safe via ingestion but which have not yet
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been evaluated for inhalation toxicity, as well as their thermal degradation products;
2. Effects of secondhand emissions, thirdhand exposures, and nicotine addiction from
e-cigarettes, especially on vulnerable populations;
3. The dynamics of pre- and post-respiration aerosols and their fate in the environment;
and
4. Life cycle and end-of-use issues.
Because of concerns about primary and secondary exposure to e-cigarette vapors and e-juice
fluids, AIHA supports risk-based regulation of e-cigarettes using reliable safety, health, and
emissions data. Current regulations for devices that are advertised for “therapeutic purposes” do
not address the multitude of e-cigarette devices and flavored e-juice formulas. However, until
reliable data can be obtained on the vapor contents, using standardized test methods and
procedures, regulatory efforts may either fall short or overreach.
E-cigarettes are likely to touch several regulatory frameworks but have, until recently, fallen
through the lattice of existing laws and regulations. The April 24, 2014, decision by the FDA to
pursue regulation of e-cigarettes as a tobacco product is the first of several possible regulatory
reviews of this product family.[80] Others include the Consumer Product Safety Commission
and OSHA. Four areas of regulation relating to the safety of primary users and people exposed
to secondhand vapors or e-juices should be considered:
1. All e-cigarette devices, whether they are being used for therapeutic or recreational
purposes, should be evaluated for potential physical and/or electrical hazards by
applicable regulatory agencies.
2. The health risks and economic consequences of accidental exposure to e-juice liquids
by children, adults, and pets should be addressed, including proper labeling and childresistant packaging requirements.
3. All future e-juice components that may be used by consumers should be fully evaluated
for any potential hazards (e.g., toxicity, flammability, safety hazards, and secondary
exposures) prior to introduction into the marketplace.
4. Because e-cigarettes are a potential source of pollutants (such as airborne nicotine,
flavorings, and thermal degradation products), their use in the indoor environment
should be restricted, consistent with current smoking bans, until and unless research
documents that they will not significantly increase the risk of adverse health effects to
room occupants.
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